Cleveland Clinic is comprised of a 1,400-bed academic medical center and 17 additional hospitals, including 5 in Southeast Florida. In total, there are nearly 6,000 inpatient beds and over 1,400 pharmacy employees, more than 300 physician practices, 20 ambulatory pharmacies, significant inpatient and outpatient clinical services and a pharmacy budget exceeding $1 billion.
The Medication-Use Safety and Policy Residency (PGY-2) is a one-year training program designed to provide an opportunity for the resident to develop necessary skills for specialized practice in medication-use systems and policies.
The program offers a variety of opportunities that allow the resident to develop skills in medication safety, drug information, formulary management, and drug-use policy development, while also incorporating aspects of administration and informatics.
Required rotations include medication safety, drug information practice, operations and administration, formulary management and implementation, and informatics. The resident will be involved with medication event reporting and monitoring, drug shortage and recall management, newsletter development and editing, and regulatory compliance. The resident will attend and present at the Cleveland Clinic Health System Medical Staff P&T Committee and corresponding Formulary Specialty Panels as well as the Cleveland Clinic Local P&T Committee. The resident will participate in journal clubs and pharmacy education conference, conduct a drug use evaluation and a research project, write a manuscript, and present one seminar.
CONTACT Medication-Use Safety and Policy Residency Director Meghan Lehmann, PharmD, BCPS Cleveland Clinic Department of Pharmacy 9500 Euclid Ave. HB 105, Cleveland, Ohio 44195 email: firstname.lastname@example.org
Interested applicants must be PharmD graduates of accredited college of pharmacy, be eligible for licensure in the State of Ohio and submit the standard application materials through PhORCAS.
Please submit all application materials via Pharmacy Online Residency Centralized Application Service (PhORCAS). Deadline for receipt of these materials to be considered for an on-site interview is January 1, 2020 by 11:59 PM. For the PGY-2 residency programs (Ambulatory Care, Cardiology, Critical Care, Emergency Medicine, Infectious Diseases, Informatics, Medication-Use Safety and Policy, Oncology, Pediatrics and Solid Organ Transplant), a Pharmacy (PGY-1) Residency or equivalent experience is required. Cleveland Clinic Health-System Residency sites agree that no person at these sites will solicit, accept, or use any ranking-related information from any residency applicant.
NOTE: 1. Residency applicants must currently be authorized to work in the United States. Cleveland Clinic Pharmacy does not sponsor applicants for work Visas. 2. Appointments of applicants to residency positions may be contingent upon the applicants satisfying certain eligibility requirements [e.g., graduating from accredited college of pharmacy, obtaining pharmacist license in Ohio (for Ohio sites) or Florida (for Florida sites) within 90 days of start date, and successful completion of a pre-employment physical and drug screen, including testing for cotinine]. 3. Unfortunately, we cannot accommodate OPT (Optional Practical Training) Visas for the Cleveland Clinic Pharmacy Residency Program as the program extends beyond 12 months. 4. The Cleveland Clinic Pharmacy Residency Program does not meet the qualifications of an OPT STEM employer because Cleveland Clinic is not enrolled in E-Verify.
Internal Number: 7
About Cleveland Clinic Main Campus
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. We are ranked among the nation’s top hospitals by U.S.News & World Report. That’s why people from across the country and around the world come here for care. A teaching and research leader, we offer exceptional career opportunities, as well as access to cutting-edge technology and innovative medical ideas.